KIDNEYRELIEF.LIFE

The Glutathione Crisis in CKD — Why Immunocal and NAC Are Non-Negotiable in the Regeneretics Protocol

In 25 years of nephrology practice, I have never met a CKD patient who was told about glutathione. Not one. They were told about phosphorus. About potassium. About creatinine. About dialysis timelines. But no one  — not their nephrologist, not their dietitian, not their pharmacist  — told them about the master antioxidant that their kidneys were running out of, and that was accelerating every dimension of their decline.

Glutathione depletion in CKD is not a side effect. It is a central mechanism of disease progression.

Let me explain the biochemistry. Uremic retention solutes  — particularly indoxyl sulfate and p-cresyl sulfate  — are generated by gut bacteria from dietary protein and are incompletely removed by damaged kidneys. These toxins have dual nephrotoxicity: they directly damage tubular cells AND they trigger the NADPH oxidase pathway, flooding the renal microenvironment with superoxide radicals. Glutathione is consumed in neutralizing these radicals. The more kidney damage, the more toxin accumulation, the more glutathione depletion  — creating the self-amplifying spiral of CKD progression.

My two primary interventions for this crisis are Immunocal and NAC.

Immunocal is not ordinary protein powder. It is a patented bioactive whey protein fraction that delivers intact bonded cysteine into cells  — the rate-limiting substrate for intracellular glutathione synthesis. Randomized controlled trials have demonstrated GSH elevation in lymphocytes, preservation of muscle mass, and immune enhancement. For my ESRD-stage patients, Immunocal Blue adds creatine and CMP for mitochondrial and renal cellular energy support.

NAC at 600mg daily provides the most bioavailable exogenous cysteine source available without prescription. Beyond glutathione precursor activity, NAC independently scavenges hydroxyl and peroxynitrite radicals and down-regulates NF-κB  — the master inflammatory transcription factor that drives fibrosis and tubular apoptosis in CKD.

In my

REGENEROS framework, I think of glutathione restoration as preparing the terrain for stem cell activity. CD34-positive stem cells  — the kidney’s own regenerative workforce  — cannot function in an oxidatively hostile microenvironment. Before we can ask the body to rebuild, we must reduce the destruction.

This is not heroic medicine. It is foundational medicine. And it is, inexplicably, medicine that most CKD patients never receive.

 

… The Quiet Power of Refusal

There is a kind of strength that does not look like strength. It looks like a woman who keeps her appointments, takes her supplements, photographs her labs, and refuses  — quietly, persistently, daily  — to accept that her story is over. That is the strength I have seen reverse the most extraordinary cases. It does not require courage. It requires persistence. You already have that. I have watched you carry it here.

 

A PERSONAL NOTE FROM DR. PRIYA

If you have never been told about glutathione depletion in CKD  — and you are now wondering whether Immunocal and NAC belong in your protocol  — write to me at care@kidneyrelief.life. I respond to every email personally. Let us look at your specific situation together.

✉ care@kidneyrelief.life